Sorafenib Inhibits Hypoxia-Inducible Factor-1 Synthesis: Implications for Antiangiogenic Activity in Hepatocellular Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-0552
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Regulation of Angiogenesis by Id-1 Through Hypoxia-Inducible Factor-1 -Mediated Vascular Endothelial Growth Factor Up-Regulation in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2006English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Rac1 Activity Is Required for the Activation of Hypoxia-Inducible Factor 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Copper-Dependent Activation of Hypoxia-Inducible Factor (HIF)-1: Implications for Ceruloplasmin Regulation

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1α Induction in Response to Hypoxic Stress and Growth Factors

Cancer Research
Cancer ResearchOncology
2005English

Synthesis and Evaluation of Novel 12-Aryl Berberine Analogues With Hypoxia-Inducible Factor-1 Inhibitory Activity

RSC Advances
ChemistryChemical Engineering
2017English

Hypoxia Inducible Factor

2011English

Increased Antitumor Activity of Bevacizumab in Combination With Hypoxia Inducible Factor-1 Inhibition

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Sorafenib Resistance in Hepatocarcinoma: Role of Hypoxia-Inducible Factors

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy